A POLYHERBAL FORMULATION TO PREVENT PROGRESSION OF ULCERATIVE COLITIS

In one aspect of the present disclosure, a polyherbal formulation including Terminalia chebula (Combretaceae), Aegle marmelos (Rutaceae), Foeniculum vulgare (Apiaceae), Cuminum cyminum (Umbelliferae/Apiaceae), Asafoetida (Umbelliferae/Apiaceae), Plantago ovata or 5 Isabgol, is disclosed. Each of the herbal constituents is in equal quantity. The formulation is for the treatment of ulcerative colitis. The formulation prevents the progression of ulcerative colitis..

Medienart:

Patent

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Europäisches Patentamt - (2021) vom: 09. Sept. Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Beteiligte Personen:

WAL PRANAY [VerfasserIn]
SHAKYA ANSHUL [VerfasserIn]
KHERA KANAV [VerfasserIn]
DUBEY SONALI [VerfasserIn]
KANNOJIA PUSHPENDRA [VerfasserIn]
KUSHWAHA SWATANTRA K S [VerfasserIn]
RAI AWANI K [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2021-09-09, Last update posted on www.tib.eu: 2024-02-05, Last updated: 2024-02-09

Patentnummer:

AU2021103912

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA014733870